Advertisement

Topics

Inspiralis Limited Company Profile

15:07 EST 9th December 2018 | BioPortfolio

Inspiralis Limited is a company which supplies high-quality research products and services to both the pharmaceutical industry and academia. We specialise in supplying topoisomerases, including bacterial DNA gyrase, topo IV, human topo I and II, as well as their substrates, (supercoiled pBR322, relaxed pBR322 and kDNA). We also provide topoisomerase inhibitor screening assays (both low and high through-put) for the bacterial and human topoisomerases.

All of our products are supported by our highly trained and experienced scientific staff. We have been supplying topoisomerase products to researchers since 1994 (recently under the name John Innes Enterprises) and we aim to continue to offer customers a robust range of products and services backed up by high-quality customer support.

As world leaders in the topoisomerase field our aim is to provide pharmaceutical companies, and others involved in drug development, with the necessary tools to develop and screen novel anti-infective and anti-cancer compounds. In order to achieve this we are constantly improving the range of products and services we offer and by listening to our customers we continue to provide an innovative approach to topoisomerase research.

Please contact us to see how we can help with your research. Unlike larger companies we can offer a tailored approach to your experiments and our technical team is available to help with superb after sales technical assistance and advice whenever you need us.

Location

Norwich Bioincubator
Norwich Research Park, Colney Lane
Norwich
Norfolk
NR4 7UH
United Kingdom

Contact

Phone: +44 (0) 1603 450924
Fax: +44 (0) 1603 450923
Email: contact@inspiralis.co.uk


News Articles [33 Associated News Articles listed on BioPortfolio]

Quotient Limited Announces Details of Investor Day

JERSEY, Channel Islands, July 16, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced details of its investor day held at the NASDAQ he...

Quotient Limited to Host Investor Day on July 16, 2018

JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it will host an Investor Day on Monday, July ...

Quotient Limited Announces Initial MosaiQ™ SDS Verification and Validation Data

JERSEY, Channel Islands, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today reported positive Verification and Validation...

Quotient Limited appoints Franz Walt as Chief Executive Officer

JERSEY, Channel Islands, May 29, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Franz Walt, as its Chief Executi...

Quotient Limited to Participate in the Jefferies 2018 London Healthcare Conference

JERSEY, Channel Islands, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Quotient (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chief Financial Officer, Chris Lindop,...

Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares

JERSEY, Channel Islands, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the Company intends to commence an ...

Quotient Limited Announces Pricing of Underwritten Offering of Ordinary Shares

JERSEY, Channel Islands, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the pricing of its previously annou...

Quotient Limited Announces Completion of Senior Secured Notes Offering

JERSEY, Channel Islands, July 02, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), has completed the offering of up to $120.0 million ...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [86 Associated Companies listed on BioPortfolio]

Inspiralis Limited

Inspiralis Limited is a company which supplies high-quality research products and services to both the pharmaceutical industry and academia. We specialise in supplying topoisomerases, including bacter...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

VASUDHA PHARMA CHEM LIMITED

VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...

More Information about "Inspiralis Limited" on BioPortfolio

We have published hundreds of Inspiralis Limited news stories on BioPortfolio along with dozens of Inspiralis Limited Clinical Trials and PubMed Articles about Inspiralis Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Inspiralis Limited Companies in our database. You can also find out about relevant Inspiralis Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record